5-Tert-butyl-4-methylthieno[2,3-c]pyridine | 1433900-35-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并吡啶类
• 英文名称: 5-Tert-butyl-4-methylthieno[2,3-c]pyridine
• 英文别名: 5-tert-butyl-4-methylthieno[2,3-c]pyridine
• CAS: 1433900-35-6
• 化学式: C₁₂H₁₅NS
• 分子量: 205.324
• InChiKey: HPJHNDWOICCWSP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  41.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-噻吩甲胺 、 4,4-二甲基-2-戊炔 在 六氟磷酸钾 、 [ruthenium(II)(η⁶-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]₂ 、 copper diacetate 作用下， 以 甲醇 为溶剂， 反应 6.0h， 以89%的产率得到5-Tert-butyl-4-methylthieno[2,3-c]pyridine
  参考文献：
  名称：

  Primary Amines as Directing Groups in the Ru-Catalyzed Synthesis of Isoquinolines, Benzoisoquinolines, and Thienopyridines

  摘要：

  Isoquinolines, benzoisoquinolines, thieno[3,2-c]pyridines and fused heteroaryl[2,3-c] pyridines, with a wide variety of substituents at different positions of the aromatic or heteroaromatic rings, have been synthesized by Ru-catalyzed oxidative coupling of a broad range of benzylamines or heterocycles with internal alkynes. All benzylamines and heterocycles have unprotected primary amines as efficient directing groups.

  DOI：

  10.1021/jo400344m

文献信息

• Heterocyclic derivatives useful as SHP2 inhibitors
  申请人：Jacobio Pharmaceuticals Co., Ltd.

  公开号：US10988466B2

  公开（公告）日：2021-04-27

  This invention relates to certain novel pyrazine derivatives (Formula I) as SHP2 inhibitors which is shown as formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention is directed to fused heterocyclic group derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.

  本发明涉及作为 SHP2 抑制剂的某些新型吡嗪衍生物（式 I）（如式 I 所示）、其合成及其用于治疗 SHP2 介导的疾病。更具体地说，本发明涉及作为 SHP2 抑制剂的融合杂环基团衍生物、生产此类化合物的方法以及治疗 SHP2 介导的疾病的方法。
• NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS
  申请人：Jacobio Pharmaceuticals Co., Ltd.

  公开号：US20200392128A1

  公开（公告）日：2020-12-17

  This invention relates to certain novel pyrazine derivatives (Formula I) as SHP2 inhibitors which is shown as formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention is directed to fused heterocyclic group derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.
• Primary Amines as Directing Groups in the Ru-Catalyzed Synthesis of Isoquinolines, Benzoisoquinolines, and Thienopyridines
  作者：Pedro Villuendas、Esteban P. Urriolabeitia

  DOI：10.1021/jo400344m

  日期：2013.6.7

  Isoquinolines, benzoisoquinolines, thieno[3,2-c]pyridines and fused heteroaryl[2,3-c] pyridines, with a wide variety of substituents at different positions of the aromatic or heteroaromatic rings, have been synthesized by Ru-catalyzed oxidative coupling of a broad range of benzylamines or heterocycles with internal alkynes. All benzylamines and heterocycles have unprotected primary amines as efficient directing groups.